These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25063383)

  • 21. Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies.
    Nan H; Park C; Maeng S
    Biomed Res Int; 2020; 2020():2408402. PubMed ID: 33344633
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapies for the bone in mucopolysaccharidoses.
    Tomatsu S; Alméciga-Díaz CJ; Montaño AM; Yabe H; Tanaka A; Dung VC; Giugliani R; Kubaski F; Mason RW; Yasuda E; Sawamoto K; Mackenzie W; Suzuki Y; Orii KE; Barrera LA; Sly WS; Orii T
    Mol Genet Metab; 2015 Feb; 114(2):94-109. PubMed ID: 25537451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.
    Sawamoto K; Stapleton M; Alméciga-Díaz CJ; Espejo-Mojica AJ; Losada JC; Suarez DA; Tomatsu S
    Drugs; 2019 Jul; 79(10):1103-1134. PubMed ID: 31209777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent trends in mucopolysaccharidosis research.
    Kobayashi H
    J Hum Genet; 2019 Feb; 64(2):127-137. PubMed ID: 30451936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme replacement therapy and substrate reduction therapy in lysosomal storage disorders with neurological expression.
    Valayannopoulos V
    Handb Clin Neurol; 2013; 113():1851-7. PubMed ID: 23622408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression-targeted isoflavone therapy.
    Węgrzyn A
    IUBMB Life; 2012 Apr; 64(4):307-15. PubMed ID: 22362546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for neurologic manifestations of mucopolysaccharidoses.
    Wolf DA; Banerjee S; Hackett PB; Whitley CB; McIvor RS; Low WC
    Expert Opin Drug Deliv; 2015 Feb; 12(2):283-96. PubMed ID: 25510418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches.
    Fraldi A; Serafini M; Sorrentino NC; Gentner B; Aiuti A; Bernardo ME
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):130. PubMed ID: 30442177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate reduction therapies for mucopolysaccharidoses.
    Jakóbkiewicz-Banecka J; Piotrowska E; Gabig-Cimińska M; Borysiewicz E; Słomińska-Wojewódzka M; Narajczyk M; Węgrzyn A; Węgrzyn G
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1860-5. PubMed ID: 21902626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatments for the mucopolysaccharidoses: from pathophysiology to therapy.
    Fecarotta S; Gasperini S; Parenti G
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):124. PubMed ID: 30442204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.
    Taylor M; Khan S; Stapleton M; Wang J; Chen J; Wynn R; Yabe H; Chinen Y; Boelens JJ; Mason RW; Kubaski F; Horovitz DDG; Barth AL; Serafini M; Bernardo ME; Kobayashi H; Orii KE; Suzuki Y; Orii T; Tomatsu S
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):e226-e246. PubMed ID: 30772512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique medical issues in adult patients with mucopolysaccharidoses.
    Mitchell J; Berger KI; Borgo A; Braunlin EA; Burton BK; Ghotme KA; Kircher SG; Molter D; Orchard PJ; Palmer J; Pastores GM; Rapoport DM; Wang RY; White K
    Eur J Intern Med; 2016 Oct; 34():2-10. PubMed ID: 27296591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurologic manifestations in mucopolysaccharidoses].
    Héron B
    Arch Pediatr; 2014 Jun; 21 Suppl 1():S14-21. PubMed ID: 25063379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mucopolysaccharidoses. New therapeutic possibilities increase the need of early diagnosis].
    Malm G; Bondeson ML; von Döbeln U; Månsson JE
    Lakartidningen; 2002 Apr; 99(16):1804-9. PubMed ID: 12043480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplant outcomes in mucopolysaccharidoses.
    Prasad VK; Kurtzberg J
    Semin Hematol; 2010 Jan; 47(1):59-69. PubMed ID: 20109613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses.
    Sato Y; Okuyama T
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative estimation of lysosomal storage in mucopolysaccharidoses by electron microscopy analysis.
    Narajczyk M; Moskot M; Konieczna A
    Acta Biochim Pol; 2012; 59(4):693-6. PubMed ID: 23230565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia.
    Nor A; Zabedah MY; Norsiah MD; Ngu LH; Suhaila AR
    Malays J Pathol; 2010 Jun; 32(1):35-42. PubMed ID: 20614724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional capacity evaluation of patients with mucopolysaccharidosis.
    Guarany NR; Schwartz IV; Guarany FC; Giugliani R
    J Pediatr Rehabil Med; 2012; 5(1):37-46. PubMed ID: 22543891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.